DPM

ESAs publish templates and tools for voluntary dry run exercise to support the DORA implementation

Retrieved on: 
Sonntag, Juni 2, 2024
European Commission, Final, Exercise, Digital, DPM, ITS, Draft, EIOPA, ICT, VBA, Workshop, EBA, ESMA

The European Supervisory Authorities (EBA, EIOPA and ESMA – the ESAs) today published templates, technical documents and tools for the dry run exercise on the reporting of registers of information in the context of Digital Operation Resilience Act (DORA) announced in April 2024.

Key Points: 
  • ESAs publish templates and tools for voluntary dry run exercise to support the DORA implementation
    The European Supervisory Authorities (EBA, EIOPA and ESMA – the ESAs) today published templates, technical documents and tools for the dry run exercise on the reporting of registers of information in the context of Digital Operation Resilience Act (DORA) announced in April 2024.
  • All these materials are available on the dry run exercise webpage.
  • Workshop
    The ESAs invite financial entities to take part in a dedicated workshop on 10 June 2024 from 10:00 to 12:00 with the aim to support their participation in the dry run exercise and introduce the materials and tools published today.
  • The final technical package for the steady-state reporting, which will start in 2025, will be published later in the year.

Dundee Precious Metals Appoints John DeCooman as Executive Vice President, Corporate Development

Retrieved on: 
Mittwoch, Mai 29, 2024
Pennsylvania State University, Mining, Mineral economics, DPM, Mineral, Business development, Corporate development, TSX, Management

TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” of “the Company”) is pleased to announce the appointment of W. John DeCooman, Jr. as Executive Vice President, Corporate Development, effective June 10, 2024.

Key Points: 
  • TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” of “the Company”) is pleased to announce the appointment of W. John DeCooman, Jr. as Executive Vice President, Corporate Development, effective June 10, 2024.
  • “I am excited to be adding John to our team.
  • From 2020 to 2023, Mr. DeCooman led the start-up of Sweetwater Royalties, a privately-held base and industrial minerals royalty company, as President and Chief Executive Officer.
  • From 2009 to 2020, he was Senior Vice President, Business Development and Strategy at SSR Mining.

Kerecis to Present Scientific and Clinical Updates on Fish-Skin Grafts at the Symposium on Advanced Wound Care Spring

Retrieved on: 
Dienstag, Mai 14, 2024
Surgery, Medical Devices, Hospitals, Health Technology, Stem Cells, Biotechnology, Other Health, Health, General Health, Patient, Mohs surgery, FNP, SAWC, Achilles tendon, Skin, DPM, Dicarboxylic acid, Research, WOCN, Regenerative medicine, Abstract, Multimedia, Foot, Female

Kerecis , the pioneer in the use of fish skin and fatty acids for tissue regeneration and protection, will unveil its latest scientific and clinical updates, including trial results, at the upcoming Symposium on Advanced Wound Care (SAWC) Spring.

Key Points: 
  • Kerecis , the pioneer in the use of fish skin and fatty acids for tissue regeneration and protection, will unveil its latest scientific and clinical updates, including trial results, at the upcoming Symposium on Advanced Wound Care (SAWC) Spring.
  • Kerecis will exhibit at booth 419 at SAWC, which will take place from May 14 to 18 in Orlando, Florida.
  • “Our ongoing research and data underscore significantly improved healing times, reduced complications, and enhanced patient outcomes across different clinical settings.
  • During a hands-on skills lab, Kerecis medical affairs program managers will demonstrate Kerecis products, highlighting advanced applications in real-world clinical settings.

The Inner Circle Acknowledges, Jonathan T. Fung, DPM, AACFAS as a Pinnacle Lifetime Member

Retrieved on: 
Montag, Mai 13, 2024
Doctorate, Grove City College, Molecular biology, Bunion, Inner circle, Health, Podiatry, Pediatrics, Trauma, American Podiatric Medical Association, Foot, DPM, Sports medicine, Arthritis, Communication, American College, Multimedia, Medical device

BLOOMFIELD, N.J., May 13, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Jonathan T. Fung, DPM, AACFAS is acknowledged as a Pinnacle Lifetime Member for his contributions as a Podiatrist.

Key Points: 
  • BLOOMFIELD, N.J., May 13, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Jonathan T. Fung, DPM, AACFAS is acknowledged as a Pinnacle Lifetime Member for his contributions as a Podiatrist.
  • Dr. Fung, a distinguished podiatrist at Curalta Foot & Ankle, is revolutionizing foot and ankle care in the local community through his commitment to excellence and patient-centered approach.
  • He prioritizes patient education and communication, ensuring that each patient is well-informed and actively involved in their treatment plan.
  • He specializes in adult orthotics, arthritis, bunion and hammertoe correction, foot and ankle surgery, pediatrics surgery, sports medicine, trauma, and reconstructive surgery.

Dundee Precious Metals Announces Voting Results from 2024 Annual Meeting of Shareholders

Retrieved on: 
Mittwoch, Mai 8, 2024
DPM, TSX, Annual general meeting, Holding company

TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (the “Company” or “DPM”) is pleased to announce the voting results from its Annual Meeting of Shareholders, which was held via live webcast on Wednesday, May 8, 2023.

Key Points: 
  • TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (the “Company” or “DPM”) is pleased to announce the voting results from its Annual Meeting of Shareholders, which was held via live webcast on Wednesday, May 8, 2023.
  • A total of 134,715,677 common shares were voted at the meeting, representing approximately 74.18% of the outstanding common shares.
  • Shareholders voted in favour of all items of business before the meeting, as follows:
    The shareholders elected each of the eight nominees listed in the Company’s management information circular.
  • Details of the voting results are set out below:

Dundee Precious Metals Continues Record of Strong Free Cash Flow Generation; Announces 2024 First Quarter Results

Retrieved on: 
Dienstag, Mai 7, 2024
Copper, PFS, Investment, Resource, Life, Capital expenditure, Mineral Resources Limited, Lithology, Legislation, IXM, Soil, Overalls, Congress, PEA, Metal, News, SPA, Kara Tepe, Economics, Water resources, Gold, Tax, Water, Krumovitsa, Vein, DPM, Complex, Ecosystem, Aparecida, Nature, EIA, Public expenditure, Government, Sale, Wedge, Capital, Biodiversity, Depreciation, MD, Analysis, Ministry, Mining

In the first quarter of 2024, the Company’s mining operations continued to deliver strong results.

Key Points: 
  • In the first quarter of 2024, the Company’s mining operations continued to deliver strong results.
  • Cash and cash equivalents of continuing operations increased by $12.7 million to $608.0 million in the first quarter of 2024 due primarily to earnings generated during the quarter.
  • On May 7, 2024, the Company declared a dividend of $0.04 per common share payable on July 15, 2024 to shareholders of record on June 30, 2024.
  • A scout drilling program, which aims to test several epithermal sediment hosted targets, commenced at the end of the first quarter of 2024.

Dundee Precious Metals Declares Dividend

Retrieved on: 
Dienstag, Mai 7, 2024
DPM, TSX, Holding company

TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) today announced that its Board of Directors has declared a second quarter dividend of US$0.04 per common share.

Key Points: 
  • TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) today announced that its Board of Directors has declared a second quarter dividend of US$0.04 per common share.
  • The dividend is payable on July 15, 2024, to shareholders of record as at 5:00 p.m. Toronto local time on June 30, 2024, and qualifies as an “eligible dividend” for Canadian income tax purposes.
  • Shareholders may elect to receive their dividend in U.S. or Canadian dollars by contacting their broker or, where applicable, Computershare Investor Services Inc., the Company’s registrar and transfer agent.
  • Dividends to be paid in Canadian dollars will be converted to Canadian dollars using the spot exchange rate on July 8, 2024.

Voom™ Medical Devices’ Bunionplasty® 360 Bunion Repair™ Solution Offers Modern Alternative to Traditional 3D Approaches

Retrieved on: 
Mittwoch, Mai 8, 2024
Biotechnology, Health, Surgery, Medical Devices, Hotel Torni, Pain, Multimedia, Regeneration, DPM, Surgeon, Bunion, Patient, 3D

Voom™ Medical Devices, Inc. ("Voom"), a human-forward medical device company leading the transformation of surgical bunion correction, has pioneered a significant advancement in the standard of care in surgical bunion repair.

Key Points: 
  • Voom™ Medical Devices, Inc. ("Voom"), a human-forward medical device company leading the transformation of surgical bunion correction, has pioneered a significant advancement in the standard of care in surgical bunion repair.
  • The company is pleased to report a rapidly accelerating interest in its proprietary, minimally invasive Bunionplasty® 360 Bunion Repair™ solution, as both surgeons and patients continue to seek multi-dimensional approaches to the pain, disfigurement, and physical limitations caused by bunions.
  • View the full release here: https://www.businesswire.com/news/home/20240507244419/en/
    Voom's proprietary fusion-free minimally invasive Bunionplasty® 360 Bunion Repair™ realigns the bones in all dimensional planes through natural bony regeneration.
  • The Bunionplasty® 360 Bunion Repair™ solution offers everything they need to move forward.”
    Surgeons who are interested in adding the Bunionplasty® 360 Bunion Repair™ solution to their practice can visit www.voommedicaldevices.com/train-with-us to learn more and begin their application.

Orthopedic & Spine Centers of Wisconsin Continues Its Growth Throughout Madison

Retrieved on: 
Mittwoch, Mai 8, 2024
Education, Orthopedic surgery, Health equity, Hospital, Suite, Elective surgery, Partnership, Foot, Spine, Patient, Physician, Public key certificate, Sports medicine, Ankle, Health, DPM, Growth, Nursing

MADISON, Wis., May 8, 2024 /PRNewswire/ -- Long-time Madison podiatrist Colin Graney, DPM, has announced both the closing of his practice and that the Board Certified and Fellowship Trained physicians at Orthopedic & Spine Centers of Wisconsin will provide continuing care for his patients. Their comprehensive team specializes in all areas of orthopedics, including a dedicated foot & ankle specialty team led by Dr. Joseph Sizensky. Other areas of expertise include orthopedic surgery, sports medicine, hand & upper extremity care, joint replacement and spine care. Orthopedic & Spine Centers of Wisconsin has several locations throughout the area, including their main office located in the Arbor Gate Complex at 2501 W Beltline Hwy, Suite 601, Madison, WI, 53713.

Key Points: 
  • Other areas of expertise include orthopedic surgery, sports medicine, hand & upper extremity care, joint replacement and spine care.
  • Orthopedic & Spine Centers of Wisconsin has several locations throughout the area, including their main office located in the Arbor Gate Complex at 2501 W Beltline Hwy, Suite 601, Madison, WI, 53713.
  • "We are honored that physicians continue to entrust the care of their patients with our growing platform," said Dr. Jason Sansone, President of Orthopedic & Spine Centers of Wisconsin.
  • Now in its second year of operations, Orthopedic & Spine Centers of Wisconsin has continued its rapid growth across the region.

APEX Orthopedics Investments Launches to Revolutionize Foot and Ankle Orthopedic Industry

Retrieved on: 
Dienstag, Mai 7, 2024
USD, University, Achilles tendon, MD, FRCSC, Foot, Ankle, Health, DPM, Anschutz Medical Campus, Investment, Nursing

AURORA, Colo., May 7, 2024 /PRNewswire/ -- APEX Orthopedics Investments, a groundbreaking asset management company dedicated to fostering innovation in the foot and ankle orthopedic sector, announces its establishment.

Key Points: 
  • AURORA, Colo., May 7, 2024 /PRNewswire/ -- APEX Orthopedics Investments, a groundbreaking asset management company dedicated to fostering innovation in the foot and ankle orthopedic sector, announces its establishment.
  • Led by a team of experts and located in the University of Colorado's Anschutz Medical Campus, APEX Orthopedics Investments is poised to transform orthopedic device development.
  • "Our mission at APEX Orthopedics Investments is to catalyze innovation within the foot and ankle orthopedic industry," stated Chris Banas, CEO and President of APEX Orthopedics Investments.
  • To learn more about APEX Orthopedics Investments and its transformative work, please visit www.APEXortho.net .